Dr. Helmut M. Schühsler is Managing Partner of TVM Capital in Munich and Boston.
Since joining TVM Capital in 1990, he has been the deal maker on more than 20 direct investments in life science companies in Europe and the U.S. and has overseen more than 80 investments in the health market in total.
Chairman and Senior Executive Officer of TVM Capital MENA Ltd., Dubai, UAE. TVM Capital MENA manages the first dedicated healthcare private equity fund for the MENA region. The Fund had a first closing at US$40m in February 2010.
In 2007 and 2008, he served as chairman of the European Private Equity and Venture Capital Association (EVCA.
He is currently the Chairman of the Supervisory Board of biotechnology companies Curacyte AG (Munich and Jena, Germany, and Durham, NC) and Develogen AG (Göttingen, Germany). He also serves as a member of the board of Max-Planck Innovation GmbH, and is a member of the Selection Committee for the Technology Pioneers program as well as the Steering Committee of the Entrepreneurship and Successful Growth Research Program of the World Economic Forum, the international advisory board of the National Technology Enterprises Corporation, Kuwait, and the advisory board of Evolvence India Life Science Fund, Hyderabad, India.
